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Abstract: 
     This study highlights the effects of iron overload on endocrine glands (Thyroid 
gland), kidney functions and liver functions in thalassemia patients in Najaf province 
in Iraq. 
One hundred patients suffering from thalassemia were 
contributed in the current study. Their age range was 3-18 years old. Thirty 
apparently healthy person  were nominated as "control group". Serum iron  
, liver functions test (AST,ALT,ALP,TSB) and Kidney functions test (Uera& 
Creatinine) were measured spectrophotometrically while 
Serum ferritin, was measured using ELISA, Thyroid hormones (T3 & T4) estimation 
by Using(I-Chroma instrument)  
     The results indicated significant increase (p<0.05) in iron , ferritin and TSB in  
patients in comparing with healthy control group while  liver functions test 
(AST,ALT,ALP ) and  Kidney functions test (Uera& Creatinin) were no       
significant.  
     We conclude from this study that Thalassemia patients in Najaf city are       
exposed to the risk of overload and the risk of oxidation. . 
thalassmic  patients are susceptible  to tissue damage produced by "oxidative stress". 
There is no statistically significant correlation noticed between each serum 
AST,ALT,TSB, Uera and Creatinin with iron status The reason is that these patients 
continue treatment(Defroxamin) that reduces iron levels in their bodies.  
Key words:Thalassemia, Thyroid hormones, liver functions test and Kidney functions 
test. 
 
Introduction: 
       Mediterranean sea anemia( Thalassemia ) is a genetic disease prevalent in most 
areas of the Middle East[1], especially Iraq, and this disease is a actual problem that 
began to increase widely. In 2010, the number of patients in Najaf province in Iraq 
was about 500 patients[2]. and the number increased to 1500 cases in 2018, according 
to information recorded in Al -Zahraa Teaching Hospital in Najaf province. 
      The treatment of this disease by blood transfusion to compensate for the 
deficiency of the amount of globin . continue the process of transfusion leads to 
increased levels of iron in the body, leading to the risk of injury and oxidation and 
deposition of iron in the endocrine, liver and kidney, The increase in iron levels leads 
to the formation of hydroxyl radicle according to the reaction of Fenton.Hydroxyl 
radical attacks unsaturated fats and has lipid peroxide [1],[2],[3]: 
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Figure (1) Mechanism of Lipid Oxidation[4] 
 
Subjects and Methods 
 
A-Patients: One hundred "Iraqi patients with β-thalassemia" 
 were contributed in the thist study. Their age about "3-18 years old". 
These patients were recorded as "β-thalassemic patients in Thallassemia Unit 
at AL-Zahra'a Teaching Hospital in" Najaf city", Iraq. The diagnosis was established 
 hemoglobin high-pressure liquid chromatography (HPLC) analysis".  
  These patients were treated by "blood transfusion". Serum CRP  "C-reactive 
protein has been estimated and has been given a negative result (CRP<6mg/L), this 
means that high ferritin  does not return to inflammation [1]. The 
this study disqualified the patients with apparent "diabetes mellitus, infection and 
inflammation, heart diseases, and patients from non-Arabic ethnic group". 
B-Controls: 30 apparently healthy person were nominated as "control group". 
Their age were similar to that of patients. 
  
Measurements: Blood samples were collected from persons in the morning 
in plain tubes and the serum separated by centrifugation after clotting. Serum levels of 
iron were estimated using Ferrozine colorimetric method [5],  
The ferritin quantitative kit based on a solid phase enzyme-linked 
immunosorbent assay (ELISA) was supplied by Monobind® Inc. USA [2]. 
T3 and T4 estimated by ichroma™ T3,T4 respectively,  the test uses a competitive 
immunodetection technique , the objective material in the taster attached  to the 
"fluorescence (FL)-labeled detection antibody", to produce the complex . This 
complex was laden to transfer onto the nitrocellulose matrix, where the "covalent 
couple of T3 or T4 and bovine serum albumin (BSA)  was immobilized on a test strip, 
and interferes with the binding of target material and FL-labeled antibody If the more 
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target material exists in blood, the less detection antibody is accumulated, resulting in 
the less fluorescence signal" [6]. 
Liver Function tests estimated spectrophotometry, Aspartate aminotransferase  (AST) 
and alanine aminotransferase (ALT) by (Randox kit)[7],while alkaline 
Phosphatase(ALP) by (Biosystem kit)[8]. 
Kidney Function test estimated spectrophotometry ,Urea by (Linear kit)[8],while 
Creatinine by (Biolabo kit)[9]. 
Results and discussions: The Clinical parameters parameters in thalassemia patients 
and controls groups as shown in the table(1). 
Table(1) The Clinical parameters parameters in thalassemic patients and healthy 
sets . 
P. Value Controls  
Mean± SD 
Patients 
 Mean± SD 
Item 
0.87 9.53±4.62 9.35±5.82 Age 
3.37 E-14 11.52 ±1.66 7.83±1.42 Hb 
3.37 E-14 37.57±4.98 26.5±4.25 PCV 
0.1461234 32.3±15.55 39.27±29.5 GOT 
0.289 30.37±14.25 38.1±52.41 GPT 
0.1487 124.5±8.055 151.9± 144.5 ALP 
3.894 E-18 0.547±0.178 1.68±0.71 TSB 
0.27 14566 33.67±8.479 31.55±8.68 Urea 
0.104 0.66 ±0.237 0.75±0.258 Creatinine 
2.01 E-13 129.3±49.879 2278.61± 1760.99 Ferritin 
4.76E-18 80.47±33.99 609.1±332.43 Iron 
0.518 1.45± 0.33 1.41±0.358 T3ng\ml 
0.5196 95.169±11.14 93.56±10.96 T4nmol\l 
 
     The results in Table (1) appearances decrease (p<0.05) in hemoglobin 
concentration and PCV in patients comparison  with the healthy  group.. This result is 
like with the  other study [10].Clinical data approve that Low hemoglobin levels may 
be associated with decreased the amount of RBC.[2]                                                                                       
     In other hand These results are probable in thalassemia which is a irregular of 
"hemolytic anemia" , "PCV" and hemoglobin decreases. Unbalanced hemoglobin 
variants characterize a unusual etiology of native hemolytic anemia finding of 
deranged hemoglobin alternates in kids with abnormal forms of hemolytic anemia, 
mainly those suffering from  beta-thalassemia trait[11].These finding are in 
accordance with the results of other studies [12]found significant decrease in PCV and 
Hb% level in value in thalassemia paitents in comparison with controls[12].                                            
The results in Table (1) show a high significant increase (p<0.05) in serum iron 
concentration in thalassemia patients as compared with the control group. These 
results show iron excess in thalassemia patients due to repeated transfusion and fast 
hemolysis. Prolonged transfusion therapy lead to iron overload that cause a extensive 
range of complications due to cardiac , hepatic and endocrine system  injury [13]. In 
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iron excess state, the iron which is originally kept as "ferritin", is placed in tissues as 
haemosiderin and this is noxious to tissue, lead to  oxidative stress [1]. 
The human body is unable to excrete  iron out of the body so the iron level in the 
body increases with repetitive blood transfusions leading to iron overload [14]. The 
accumulation of unbounded iron leads to free radical synthesis based on the reaction 
of Fenton, which causes the risk of oxidation to the body organs [2]. 
Result of serum ferritin in thalassemia patients than controls explain in figure (1). 
 
 
Figure (1): Clinical parameters (Iron and ferritin )  in thalassemia patients and 
controls groups  
       These results presented a significantly high  ferritin level  in thalassemia patients 
in comparison with the healthy group. these results indicate iron overload in the 
patients group due to the fact that ferritin is used as a marker for iron overload 
disorders, such as "hemochromatosis" and "hemosiderosis". The signs and symptoms 
of high ferritin levels include weariness, lethargy, pain in the abdomen, deficiency of 
sex energy and several heart problems [15]. 
Result of serum thyroid function (T3, T4) in thalassemia patients than controls 
explain in table (1) and in figure (2): 
 
 
Figure (2): Clinical parameters (T3 and T4 )  in thalassemia patients and 
controls groups 
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thyroid function tests (T3, T4) were near to healthy values. This study included 
thalassemia patients aged 3 to 18 years and signs of hypothyroidism were evident 
after the second decade of age, so the outcome was normal[16] 
There is no significant difference between patients and control group for both urea 
and creatinine as indicated in figure(3).  
 
 
 
Figure (3): Clinical parameters (Urea and Creatinin ) in thalassemia patients 
and controls groups 
      This is due to continuous follow-up of patients and adherence to treatment as 
mentioned in their files. 
These results are not consistent with some studies that mention the high level of urea 
and creatinine in patients with thalassemia compared to healthy people[17]. 
As for liver function, the study showed no significant difference between control 
group and patients except (TSB), as shown in the figure (4). 
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Figure (4): Liver Function Test  in thalassemia patients and controls groups         
                                       
This results proved that the use of chelating agent  and the continuous follow-up of 
patients to remove excess iron leads to the preservation of the integrity of liver cells 
from damage and the risk of oxidation and thus remain concentrations of liver 
enzymes within the normal level, this result is consistent with another study[18] 
In the other hand this  study disagrrement with some other studies that show increased 
concentrations of liver enzymes in patients with thalassemia due to the effect of 
excess iron that causes liver tissue damage [19].  
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